PMCK Berhad (0363.KL) has a MoatMap StockRank of 76/100 based on Quality (69/100), Value (48/100), and Momentum (44/100) factor scores. The current signal is BUY. Generic drug manufacturer with thin margins, highly vulnerable to rising input costs and lacking the proprietary IP or CDMO pricing power required for our portfolio.
PMCK Berhad operates private hospitals, specialized clinics, and ambulatory care centers across Malaysia. The company benefits from a strong reputation for clinical excellence and a growing network of localized healthcare facilities. It is a defensive healthcare provider positioned to capture demand from Malaysia's aging population and growing medical tourism sector.
| Price | $0.05 |
| Market Cap | $54M |
| P/E (TTM) | 20.00 |
| P/E (Forward) | 0.17 |
| Price/Book | 1.38 |
| Return on Equity | 12.8% |
| Return on Invested Capital | 22.8% |
| Debt/Equity | 20.51 |
| Gross Margin | 31.1% |
| Operating Margin | 24.4% |
| Dividend Yield | 1.2% |
| Free Cash Flow | $-246K |
PMCK Berhad operates in the Medical Care Facilities industry, part of the Healthcare sector (Malaysia).